Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.86 extracted from

  • Sheppeck, J.E.; Gilmore, J.L.; Yang, A.; Chen, X.; Xue, C.; Roderick, J.; Liu, R.; Covington, M.B.; Decicco, C.P.; Duan, J.J.
    Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE) (2007), Bioorg. Med. Chem. Lett., 17, 1413-1417.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
(5R,6R)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.4]nonane-6-carboxamide
-
Sus scrofa
(5R,6S)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.4]nonane-6-carboxamide
-
Sus scrofa
(5S,6R)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide
-
Sus scrofa
13-[(4R)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]tridecanamide
-
Sus scrofa
2-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]acetamide
-
Sus scrofa
2-[(5R,6S)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]acetamide
-
Sus scrofa
7-(1-methyl-2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
-
Sus scrofa
7-(2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
-
Sus scrofa
7-(3-methyl-2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
-
Sus scrofa
7-[(4R)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
-
Sus scrofa
7-[(4S)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
-
Sus scrofa
N-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.5]dec-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[(5R,6S)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[(5R,9R)-2,4-dioxo-1,3,7-triazaspiro[4.4]non-9-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[(5R,9R)-7-(2-methylpropanoyl)-2,4-dioxo-1,3,7-triazaspiro[4.4]non-9-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[1-(2,5-dioxoimidazolidin-4-yl)ethyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
N-[[(4R)-2,5-dioxoimidazolidin-4-yl]methyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
-
Sus scrofa
tert-butyl (5R,9R)-9-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]-2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylate
-
Sus scrofa

Organism

Organism UniProt Comment Textmining
Sus scrofa
-
-
-

Synonyms

Synonyms Comment Organism
ADAM-17
-
Sus scrofa
TACE
-
Sus scrofa
tumor necrosis factor-alpha converting enzyme
-
Sus scrofa

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.000011
-
-
Sus scrofa (5S,6R)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide
0.000013
-
-
Sus scrofa tert-butyl (5R,9R)-9-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]-2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylate
0.000017
-
-
Sus scrofa 2-[(5R,6S)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]acetamide
0.000024
-
-
Sus scrofa N-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.5]dec-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.000024
-
-
Sus scrofa N-[(5R,9R)-7-(2-methylpropanoyl)-2,4-dioxo-1,3,7-triazaspiro[4.4]non-9-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.000025
-
-
Sus scrofa N-[(5R,9R)-2,4-dioxo-1,3,7-triazaspiro[4.4]non-9-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.000028
-
-
Sus scrofa N-[1-(2,5-dioxoimidazolidin-4-yl)ethyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.000029
-
-
Sus scrofa N-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.000064
-
-
Sus scrofa (5R,6S)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.4]nonane-6-carboxamide
0.000098
-
-
Sus scrofa N-[[(4R)-2,5-dioxoimidazolidin-4-yl]methyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.00015
-
-
Sus scrofa 13-[(4R)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]tridecanamide
0.00017
-
-
Sus scrofa 7-[(4R)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
0.00021
-
-
Sus scrofa 7-(2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
0.00023
-
-
Sus scrofa (5R,6R)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]-2,4-dioxo-1,3-diazaspiro[4.4]nonane-6-carboxamide
0.0009
-
-
Sus scrofa N-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.0037
-
-
Sus scrofa 7-[(4S)-2,5-dioxoimidazolidin-4-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
0.0055
-
-
Sus scrofa N-[(5R,6S)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
0.0074
-
-
Sus scrofa 2-[(5R,6R)-2,4-dioxo-1,3-diazaspiro[4.4]non-6-yl]-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]acetamide
1
-
-
Sus scrofa 7-(1-methyl-2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide
1
-
-
Sus scrofa 7-(3-methyl-2,5-dioxoimidazolidin-4-yl)-N-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]heptanamide